Haisco Pharmaceutical Group Co (SZSE:002653) 3-Year Book Growth Rate : 12.50% (As of Mar. 2025)

View and export this data going back to 2012. Start your Free Trial

What is Haisco Pharmaceutical Group Co 3-Year Book Growth Rate?

Haisco Pharmaceutical Group Co's Book Value per Share for the quarter that ended in Mar. 2025 was ¥3.68.

During the past 12 months, Haisco Pharmaceutical Group Co's average Book Value per Share Growth Rate was -4.70% per year. During the past 3 years, the average Book Value per Share Growth Rate was 12.50% per year. During the past 5 years, the average Book Value per Share Growth Rate was 11.40% per year. During the past 10 years, the average Book Value per Share Growth Rate was 7.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Haisco Pharmaceutical Group Co was 56.40% per year. The lowest was -78.50% per year. And the median was 8.50% per year.

Competitive Comparison of Haisco Pharmaceutical Group Co's 3-Year Book Growth Rate

For the Biotechnology subindustry, Haisco Pharmaceutical Group Co's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Haisco Pharmaceutical Group Co's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Haisco Pharmaceutical Group Co's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Haisco Pharmaceutical Group Co's 3-Year Book Growth Rate falls into.

Save Embed

;

Save Embed

;

Haisco Pharmaceutical Group Co 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Haisco Pharmaceutical Group Co (SZSE:002653) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Haisco Pharmaceutical Group Co 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Haisco Pharmaceutical Group Co's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Haisco Pharmaceutical Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Haisco Pharmaceutical Group Co Ltd (SZSE:002653) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 17, Sanxiang Avenue, Shannan District, Tibet Autonomous Region, Zetang, CHN, 856000

Website

http://www.haisco.com

Haisco Pharmaceutical Group Co Ltd is a pharmaceutical company based in China. It is mainly engaged in the research, development, manufacture, and sale of drugs for liver disease. Its product portfolio includes parenteral nutrition drugs, antibiotics, anesthetic agents, digestive system drugs and tumour adjuvant drug series. The company's products are being used in first rank hospitals in China.

Executives

Fan Xiu Lian	Directors, executives
Zheng Wei	Directors, executives
Wang Meng	Secretary Dong
Wang Jun Min	Directors, executives
Deng Xiang	Directors, executives
Liu Han Bing	Supervisors
Zhang Xiao Xu	Supervisors
Tan Hong	Executives
Shen Ping	Director
Liang Yong	Supervisors
Chen Long	Independent director
Duan Qing Liang	Supervisors

Haisco Pharmaceutical Group Co Headlines

No Headlines